Summary
Short-term administration of physiological amounts of C-peptide to patients with insulin-dependent diabetes was found to reduce the glomerular hyperfiltration in these patients as well as augment whole body glucose utilization. It could also be shown that C-peptide administration increases blood flow, oxygen uptake and capillary diffusion capacity of exercising forearm muscle in IDDM patients, probably by increasing capillary recruitment in the working muscle. Studies under in vitro conditions have shown that C-peptide stimulates glucose transport in skeletal muscle with its maximal effect within the physiological concentration range. The findings in a clinical study in which IDDM patients were given C-peptide and insulin or insulin alone for 4 weeks in a double-blind randomized study design, indicate that C-peptide improves renal function by reducing urinary albumin excretion and glomerular filtration, decreases blood retinal barrier leakage and improves metabolic control. Preliminary findings suggest that C-peptide administration on a short-term basis (3 h) may ameliorate autonomic neuropathy by restoring to near normal the heart rate variability in response to expiration and inspiration. Insight into a possible mechanism of action of C-peptide is provided by the finding that C-peptide stimulates Na+K+-ATPase activity in renal tubular segments. In conclusion, the present results suggest that, contrary to the prevailing view, C-peptide possesses important physiological effects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- GFR:
-
glomerular filtration rate
- NEFA:
-
non-esterified fatty acids
- CDC:
-
capillary diffusion capacity
References
Steiner DF, Oyer PE (1967) The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci USA 57: 473–480
Steiner DF, Cunningham D, Spigelman L, Aten B (1967) Insulin biosynthesis: evidence for a precursor. Science 157: 697–700
Steiner DF, Kemmler W, Howard S, Peterson T, Peterson J (1974) Proteolytic processing in the biosynthesis of insulin and other proteins. Federation Proc 33: 2105–2115
Steiner D (1978) On the role of the proinsulin C-peptide. Diabetes 27 [Suppl 1]: 145–148
Kitabchi AE (1970) The biological and immunological properties of pork and beef insulin, proinsulin, and connecting peptides. J Clin Invest 49: 979–987
Solomon SS, Brush JS, Kitabchi AE (1970) Antilipolytic activity of insulin and proinsulin on ACTH and cyclic nucleotide-induced lipolysis in the isolated adipose cell of rat. Biochim Biophys Acta 218: 167–169
Yu SS, Kitabchi AE (1973) Biological activity of proinsulin and related polypeptides in the fat tissue. J Biol Chem 248: 3753–3761
Kitabchi AE (1977) Proinsulin and C-peptide: a review. Metabolism 26: 547–587
Hagen C, Faber OK, Binder C, Alberti KGMM (1977) Lack of metabolic effects of C-peptide in normal subjects and juvenile diabetic patients. Acta Endocrinol 85 [Suppl 209]: 29A (Abstract)
Hoogwerf BJ, Bantle JP, Gaenslen HE et al. (1986) Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 35: 122–125
Madsbad S (1983) Prevalence of residual beta-cell function and its metabolic consequences in type 1 (insulin-dependent) diabetics. Diabetologia 24: 141–147
Madsbad S (1983) Factors of importance for residual betacell function in type 1 diabetics. A review. Acta Med Scand 671: 61–67
Madsbad S, McNair P, Faber OK, Binder C, Christiansen, Transbol J (1980) Beta-cell function and metabolic control in insulin-dependent treated diabetics. Acta Endocrinol (Copenh) 93: 196–200
Sjöberg S, Gunnarsson R, Gjötterberg M, Persson A, Östman J (1987) Residual insulin production and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 208–213
Faber O, Binder C (1977) B-cell function and blood glucose control in insulin-dependent diabetes within the first month of insulin treatment. Diabetologia 13: 263–268
Sjöberg S, Gjötterberg M, Berglund L, Möller E, Östman J (1991) Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type 1 (insulin-dependent) diabetes mellitus. J Diabetes Complications 5: 18–22
Kernell A, Ludvigsson J, Finnström K (1990) Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and C-peptide levels. Acta Ophthalmologica (Copenh) 68: 415–420
Stalder G, Schmid R (1959) Severe functional disorders of glomerular capillaries and renal hemodynamics in treated diabetes mellitus during childhood. Ann Pediatr (Paris) 193: 129–138
Mogensen CE, Andersen MJF (1973) Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 706–712
Mogensen CE, Andersen MJF (1975) Increased kidney size and glomerular filtration rate in untreated juvenile diabetes. Normalisation by insulin treatment. Diabetologia 11: 221–224
Sandahl-Christiansen J, Frandsen M, Parving HH (1981) The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 20: 199–204
Rabkin R, Ross BD, Mako ME, Rubenstein AH (1978) The handling of insulin, proinsulin, and C-peptide by the isolated rat kidney. Diabetes 27 [Suppl 2]: 192–196
Henriksen JH, Tronier B, Bülow JB (1987) Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man. Metabolism 35: 463–468
Sjöberg S, Johansson B-L, Östman J, Wahren J (1991) Renal and splanchnic exhange of human biosynthetic C-peptide in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32: 423–428
Johansson B-L, Sjöberg S, Wahren J (1992) The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 121–128
Johansson B-L, Kernell A, Sjöberg S, Wahren J (1993) Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77: 976–981
Kernell A, Tenland T (1982) Vitreous fluorophotometry — an evaluation of an instrument for the study of diabetic retinopathy. Innov Tech Biol Med 3: 320–327
Kernell A, Larsson Y, Ludvigsson J, Tenland T (1980) Vitreous fluorophotometry in juvenile diabetes. Acta Endocrinol 94 [Suppl 238]: 67–74
Kernell A, Ludvigsson J (1985) Blood-retinal barriers in juvenile diabetics in relation to early clinical manifestations. Graefers Arch Clin Exp Opthalmol 222: 250–253
Kohner EM, Lawson PM, Ghosh G, Teata M Kroc collaborative study group (1985) Assessment of fluorescein angiograms. Diabetes 35 [Suppl 3]: 56–60
White NH, Waltman SR, Krupin T, Santiago JV (1982) Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control. Diabetes 31: 80–85
Johansson B-L, Linde B, Wahren J (1992) Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 1151–1158
Wojcikowski CZ, Maier V, Dominiak K, Fussgänger R, Pfeiffer EF (1983) Effects of synthetic rat C-peptide in normal and diabetic rats. Diabetologia 25: 288–290
Zierath JR, Galuska D, Johansson B-L, Wallberg-Henriksson H (1991) Effect of human C-peptide on glucose transport in in vitro incubated skeletal muscle. Diabetologia 34: 899–901, 1991
Dohm GL, Tapscott EB, Pories WJ (1988) An in vitro muscle preparation suitable for metabolic studies. J Clin Invest 82: 486–494
Zierath JR, Thörne A, Johansson B-L, Wallberg-Henriksson H (1990) C-peptide stimulates glucose transport in type 1 diabetic skeletal muscle. Diabetologia 33 [Suppl]: A226 (Abstract)
Trap-Jensen J (1970) Increased capillary permeability to 131Iodide and [51Cr] EDTA in the exercising forearm of longterm diabetics. Clin Sci 39: 39–49
Persson MG (1991) Studies on metabolic, myogenic, and neurogenic control of skeletal muscle microcirculation. Thesis, Karolinska Institute ISBN 91-628-0418-9
Dieterle P, Birkner B, Gmeiner K-H et al. (1973) Release of peripherally stored insulin during acute muscular work in man. Horm Metab Res 5: 316–322
Flatt PR, Swanston-Flatt SK, Hampton SM, Bailey CJ, Marks V (1986) Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor. Biosci Rep 6: 196–199
Sweadner KJ, Goldin SM (1980) Active transport of sodium and potassium ions. New Engl J Med 302: 777–782
Doucet A, Katz AI, Morel F (1979) Determination of Na-K-ATPase activity in single segments of mammalian nephron. Am J Physiol 237: F105-F113
Wahren J, Ohtomo Y, Johansson B-L and Aperia A (1994) C-Peptide stimulates renal Na+K+ATPase. Eur J Endocrinol 130 [Suppl 1]: 38
Greene DA, Lattimer S, Ulbrecht J, Carroll P (1985) Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 8: 290–299
Johansson B-L, Borg C, Fernqvist-Forbes E, Odengren T, Remal S, Wahren J (1994) Human biosynthetic C-peptide improves autonomic nerve function in patients with type 1 diabetes. Eur J Endocrinol 130 [Suppl 1]: 25
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wahren, J., Johansson, B.L. & Wallberg-Henriksson, H. Does C-peptide have a physiological role?. Diabetologia 37 (Suppl 2), S99–S107 (1994). https://doi.org/10.1007/BF00400832
Issue Date:
DOI: https://doi.org/10.1007/BF00400832